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Optimizing Outcome of
Transcatheter Aortic
Valve Replacement
It Is All About Geometry*
Lutz Buellesfeld, MD
Bern, Switzerland
Aortic valve stenosis and its treatment is not a “black box.”
It is not like a genetic disorder resulting in a complex
syndrome that requires a very profound understanding and
a sophisticated therapeutic approach; it is not like arterial
hypertension, with a broad set of competing treatment
alternatives and yet a somewhat unpredictable interindi-
vidual response to a chosen regimen, with a need for
constant monitoring and adjustments. Aortic valve stenosis
is a simple mechanical problem that requires a mechanical
solution. That is the reason why surgical aortic valve
replacement has been the successful gold standard treatment
for decades in patients with symptomatic and severe aortic
valve disease. This also explains why transcatheter aortic valve
replacement (TAVR) could emerge as a suitable therapeutic
alternative in the past decade and is now established for
inoperable and high-risk surgical candidates (1).
See page 462
Among various major technical and logistic differences as
well as still-open questions on comparability, particularly
with regard to durability and performance in moderate and
lower-risk patients, a rather significant difference between
surgical aortic valve replacement and TAVR lies in the valve
accessibility. In surgery, the direct open access allows for a
straightforward visual assessment of the relative aortic root
geometry (even absolute for the annulus dimensions) and a
highly controlled implantation of the prosthetic heart valve,
which virtually excludes malpositioning and suboptimal
hemodynamic outcomes, at least in the vast majority of
patients.
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edtronic and Edwards Lifesciences.In contrast, TAVR lacks this direct open access, which
makes this approach highly dependent on “accessory” tools,
namely imaging techniques such as echocardiography, com-
puted tomography, and fluoroscopy, to precisely display and
assess the aortic root geometry for optimal device selection
and procedural guidance. In other words, imaging is man-
datory to pick and place the proper device. In addition, in
case of suboptimal procedural results, which in fact are
always related to mechanical issues, imaging techniques are
the only tools to detect and evaluate the cause of failure.
The recent advent of advanced 3-dimensional imaging
techniques such as 3-dimensional computed tomography
reconstruction and 3-dimensional echocardiography has
markedly improved our understanding of the aortic root
geometry. Based on this new understanding as well as the
capabilities of modern imaging techniques, our TAVR
device selection policy is currently moving from a diameter-
based decision strategy toward a perimeter- and area-based
approach, which better reflects the 3-dimensional character-
istics of the annulus structure. Although there is currently
only scarce evidence on this topic, this little evidence is
rapidly growing, and the application of these innovations
translates into improved outcomes as it enhances our ap-
preciation for geometric requirements, issues, and limita-
tions of TAVR.
In this context, Binder et al. (2) report in this issue of
JACC: Cardiovascular Interventions the results of an inter-
esting study evaluating the impact of post-implant device
geometry and position on conduction disturbances, hemo-
dynamic performance, and paravalvular regurgitation in
patients with symptomatic aortic valve stenosis undergoing
TAVR using the balloon-expandable Edwards Sapien XT
prosthesis (Edwards Lifesciences, Irvine, California). A
total of 89 patients were enrolled and underwent pre- and
post-procedural multidetector computed tomography
(MDCT) and 2-dimensional echocardiography. The inves-
tigators looked at various geometric parameters such as
device expansion at the inflow level, mid-portion and
outflow level, device circularity, device-to-annulus relation-
ships, and implant height. Particularly the use of MDCT
before and after the procedure yielded interesting data,
which makes this paper a relevant contribution.
Geometry and Conduction Disturbances
The main conclusion presented by Binder et al. (2) is
actually not new: a low device placement (implant height)
(Fig. 1) with a relevant segment extending into the left
ventricular outflow tract predicts the occurrence of severe
atrioventricular conduction disturbances and need for
permanent pacing.
It is well known that any intervention within the aortic
annulus carries a risk for conduction disturbances due to the
close proximity of the relevant anatomic structures, and this
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470holds particularly true for TAVR. In 2009, Guiterrez et al.
(3) already described this association in a series of patients
undergoing transapical implantation of the balloon-
expandable Edwards prosthesis, but in fact the majority of
previous publications on this topic is based on patient
populations treated with the self-expanding Medtronic
CoreValve prosthesis (Medtronic, Minneapolis, Minne-
sota), suggesting an implant height of 6 mm to avoid
relevant conduction disturbances (4). Therefore, the current
paper provides another piece of evidence that this compli-
cation is obviously not device-specific, but it is related to
procedural characteristics. Contemporary implantation
strategies aiming for higher implant levels are actually the
consequence of this known finding, with marked reduction
in permanent pacemaker implantation rates in more recent
publications. However, this modern implantation strategy is
obviously conflicted by the risk of coronary occlusions in
case of high straight stent frame designs, which certainly can
pose a conceptual dilemma.
Another finding described in this paper is the fact that
annular oversizing was not associated with conduction
disturbances and the need for permanent pacing. Virtual
area oversizing, defined as the relationship between nominal
device area to annulus area, as well as effective area oversiz-
ing, defined as device area of the actual implant compared
with the baseline annulus area (Fig. 2), are surrogate
markers of applied radial forces onto the surrounding tissue.
The higher the oversizing, the greater the potential stress to
the native anatomy. One might expect that significant stress
Figure 1. Concept of Device Implant Height in Relation to
Annulus and LVOT
The device implant height is deﬁned as the distance between the inﬂow
stent frame edge to the aortic annulus. The height can amount to different
values depending on the projection in case of device-to-annulus misalign-
ment with a tilted device implant. Any implant height 0 mm means
extension of the device into the left ventricular outﬂow tract (LVOT).within the annulus area may provoke conduction distur-bances. However, this is not exactly the case for the simple
reason that what matters most is the stress applied to the
conduction system itself and not to a more or less remote
structure. As the bundle of His and the left bundle branches
penetrate and run on the superior edge of the muscular
septal portion with a superficial subendocardial course in the
left ventricular outflow tract (LVOT), it is relevant to look
at the radial impact of a TAVR device at the LVOT level
rather than at the annulus level. The above-mentioned effect
of implant height supports this concept and is actually its
consequence. Unfortunately, in the past, we focused very
exclusively on the annulus and somewhat ignored the
LVOT device geometry, although LVOT trauma by over-
sizing and overexpansion is probably the key issue when
conduction disturbances are observed. The present paper
does not concentrate on this topic, but several studies are
ongoing and will shortly provide further insights. Particu-
larly, the capabilities and precision of 3-dimensional aortic
root reconstruction by MDCT generate a new level of
imaging that boosts our geometric understanding and helps
to focus on these new aspects.
Geometry and Hemodynamic Performance
Geometry and hemodynamics are interdependent, as ex-
pressed by the Bernoulli principle or the continuity equa-
tion. Having said this, another finding described by Binder
et al. is somewhat surprising. The investigators analyzed the
impact of device expansion, device eccentricity, and labeled
prosthesis size on post-procedural valve gradients and mea-
sured effective orifice areas. Only the labeled prosthesis size
was found to affect gradient and orifice area; expansion and
eccentricity did not. Whereas the former association is
explainable, given the larger dimensions of larger device
sizes, the latter is not. Reporting this finding is probably
correct from the statistical point of view in the small cohort
enrolled, but it is not likely to hold up in larger series as it
speaks against physical laws. Optimal device expansion,
meaning the best expansion for a given anatomy, is still the
goal for a successful TAVR procedure.
Geometry and Post-Procedural
Aortic Regurgitation
Finally, the investigators also focused on geometric device
characteristics and the incidence of post-procedural aortic
regurgitation. Paravalvular regurgitation is probably the
most obvious geometric issue in the context of TAVR. The
device needs to fit into the native annulus in order to stay
there and to function properly. Whereas oversized devices
carry the risk of annulus or LVOT rupture, particularly
when using a balloon-expandable device, undersizing may
lead to incomplete anchoring with risk for device emboli-
zation, incomplete expansion with relevant gradients as
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471detailed herein, and incomplete sealing resulting in paraval-
vular leaks. In addition, device underexpansion or leaflet
destruction or immobility can cause valvular regurgitation,
which must be differentiated from a paravalvular leak.
Binder et al. did not state the number of valvular leaks, but
they did report paravalvular leaks in 67 patients, ranging
from mild in 67% of the population to moderate in 6% and
severe in 2%. The identified predictive geometric parameter
for occurrence of paravalvular regurgitation was the relation
of inflow stent frame area and annulus area. This finding
corroborates the underlying mechanical concept that the
device must be adequately sized for complete sealing to
avoid paravalvular gaps. However, the issue of paravalvular
regurgitation is more complex, as it is not only the result of
device and annulus dimensions, but also of calcification
Figure 2. Pre-Procedural and Post-Procedural MDCT Parameters of Aortic
Annulous and Device Geometry
Three-dimensional multidetector computed tomography (MDCT) recon-
struction of the aortic annulus allows for a precise evaluation of the annu-
lus geometry. In addition to diameters, annulus perimeter and area as well
as virtual and actual device dimensions and relative and absolute relation-
ships can be assessed.patterns, which we are just starting to acknowledge and to tinvestigate in full extent with modern imaging capabilities.
When doing so, it is important to match corresponding
geometries, which is not exactly the case in the highlighted
relationship of inflow stent frame area to annulus area, as
the inflow stent frame usually acts in the LVOT level rather
than the area level, unless the device has an implant height
of 0 mm.
Conclusions
Geometry, dimensions, and spatial relationships are the
cornerstones for a successful TAVR procedure. Particularly,
the recent innovations in the field of imaging improved
substantially our screening capabilities and device selection
process along with our understanding of the human aortic
root anatomy. These developments enable us to perform
TAVR in a safer, more effective, and more predictable way
than we did in the early years. And this progress is ongoing.
Imaging tools are the reason why interventional treatment
of aortic valve stenosis is not a black box, but a transparent
one that reveals its contents. The surgeon uses a different
way; he or she just opens that box. Yet, this direct access
does not necessarily prevent a blurred view, as expressed in
a recent noteworthy publication: “The everyday used no-
menclature of the aortic root components: the tower of
Babel?” (5). So what Goethe said centuries ago is still
somewhat true: “This is the most difficult thing of all,
though it would seem the easiest: to see that which is before
one’s eyes.” However, we are making progress.
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